NEWS & EVENTS
NIBIB researchers have created a nanovaccine that could make a current approach to cancer immunotherapy more effective while also reducing side effects. Read more at www.ALNmag.com.
A new, inexpensive method for detecting salt concentrations in sweat or other bodily fluids has been developed by biomaterials scientists. The fluorescent sensor, derived from citric acid molecules, is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis. Read more at Penn State News.
A computer program has been developed that uses radiomic features found in routine MRI scans to distinguish between radiation necrosis and recurrent brain cancer. In a comparison, the program was nearly twice as accurate as a pair of radiologists. Read more at NDTV.
Researchers have discovered a new technique for generating rapidly-differentiating human neural stem cells for use in a variety of tissue engineering applications, including a three-dimensional model of the human brain, according to a new report. Read more at TuftsNow.
NIBIB grantee Kullervo Hynynen has won the Focused Ultrasound Foundation's 2016 Visionary Award. Hynynen has been instrumental in the development of the first clinical system for MR-guided focused ultrasound. Read more at http://www.fusfoundation.org